Biometric Research Institute

Biometric Research Institute (BRI) was a prominent Contract Research Organization (CRO) that provided clinical trial management, data management, and regulatory consulting services to the pharmaceutical and biotechnology industries. Founded in 1978 and headquartered in Arlington, Virginia, the company established a strong reputation for its expertise in biostatistics and navigating complex FDA approval processes. BRI specialized in high-stakes therapeutic areas, including oncology and cardiovascular disease, serving a diverse range of global clients. In 1996, the company was acquired by Quintiles Transnational (now IQVIA) for approximately $110 million, a move that significantly enhanced Quintiles' regulatory and clinical data capabilities. Today, BRI's legacy continues through the integrated service offerings of IQVIA.